Roivant Sciences
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$4.7B
Focus Areas
3
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Immunovant | $4.7B |
| Affimed | $3.0M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Immunovant | $4.7B |
| Affimed | $3.0M |